Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination

Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination

Several lines of evidence suggest that binding SARS-CoV-2 antibodies such as anti-SARS-CoV-2 RBD IgG (anti-RBD) and neutralising antibodies (NA) are correlates of protection against SARS-CoV-2, and the correlation of anti-RBD and NA is very high. The effectiveness (VE) of BNT162b2 in preventing SARS...

Full description

Bibliographic Details
Main Authors: Angelos Hatzakis, Andreas Karabinis, Sotirios Roussos, Nikos Pantazis, Dimitrios Degiannis, Antigoni Chaidaroglou, Konstantinos Petsios, Ioanna Pavlopoulou, Sotirios Tsiodras, Dimitrios Paraskevis, Vana Sypsa, Mina Psichogiou
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Vaccines
Subjects:
COVID-19
BNT162b2 vaccine
health care workers
immune response
anti-RBD
kinetics
Online Access:https://www.mdpi.com/2076-393X/10/2/285

Internet

https://www.mdpi.com/2076-393X/10/2/285

Similar Items